7 alpha-hydroxy-4-cholesten-3-one and Bile Duct Obstruction, Extrahepatic

7 alpha-hydroxy-4-cholesten-3-one has been researched along with Bile Duct Obstruction, Extrahepatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DePaoli, AM; Elliott, M; Ko, B; Learned, RM; Lindhout, DA; Ling, L; Luo, J; Phung, V; Tian, H; To, C; Zhou, M	1

Trials

1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Bile Duct Obstruction, Extrahepatic

Article	Year
A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Science translational medicine, 2014, Jul-30, Volume: 6, Issue:247 Topics: Adult; Animals; Australia; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Double-Blind Method; Down-Regulation; Fibroblast Growth Factors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Variation; Healthy Volunteers; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Recombinant Proteins; Risk Assessment; RNA, Messenger; Young Adult	2014

Article

Year

A nontumorigenic variant of FGF19 treats cholestatic liver diseases.

Science translational medicine, 2014, Jul-30, Volume: 6, Issue:247

Topics: Adult; Animals; Australia; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cholestasis, Extrahepatic; Cholestasis, Intrahepatic; Cholestenones; Cholesterol 7-alpha-Hydroxylase; Disease Models, Animal; Double-Blind Method; Down-Regulation; Fibroblast Growth Factors; Gene Expression Regulation, Enzymologic; Gene Transfer Techniques; Genetic Variation; Healthy Volunteers; Humans; Liver; Liver Neoplasms; Male; Mice; Middle Aged; Recombinant Proteins; Risk Assessment; RNA, Messenger; Young Adult

2014